Dosage of Dexclorfeniramina in details
Dexclorfeniramina Dosage
Applies to the following strengths: 2 mg/5 mL; 4 mg; 6 mg; 2 mg
Usual Adult Dose for:
- Allergic Reaction
- Allergic Rhinitis
Usual Pediatric Dose for:
- Allergic Reaction
- Allergic Rhinitis
Additional dosage information:
- Renal Dose Adjustments
- Liver Dose Adjustments
- Dose Adjustments
- Precautions
- Dialysis
Usual Adult Dose for Allergic Reaction
Initial dose: 2 mg (1 teaspoonful) orally every 4 to 6 hours, or 4 to 6 mg of the timed-release preparation at bedtime or every 8 to 10 hours
Usual Adult Dose for Allergic Rhinitis
Initial dose: 2 mg (1 teaspoonful) orally every 4 to 6 hours, or 4 to 6 mg of the timed-release preparation at bedtime or every 8 to 10 hours
Usual Pediatric Dose for Allergic Reaction
2 years to 5 years: 0.5 mg (1/4 teaspoonful) every 4 to 6 hours for children 2 to 5 years old (do not use timed release)
6 years to 11 years: 1 mg (1/2 teaspoonful) every 4 to 6 hours, or 4 mg of the timed-release preparation at bedtime
Usual Pediatric Dose for Allergic Rhinitis
2 years to 5 years: 0.5 mg (1/4 teaspoonful) every 4 to 6 hours for children 2 to 5 years old (do not use timed release)
6 years to 11 years: 1 mg (1/2 teaspoonful) every 4 to 6 hours, or 4 mg of the timed-release preparation at bedtime
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Dose Adjustments
Dosage should be individualized according to the needs and the response of the patient.
Precautions
Dexclorfeniramina is contraindicated in newborns or premature infants and in nursing mothers.
As in adults, antihistamines may diminish mental alertness in children, in the young children particularly, they may produce excitation.
Because antihistamines may have potent anticholinergic properties, Dexclorfeniramina meets Beers criteria as a medications that is potentially inappropriate for use in older adults.
Dialysis
Data not available
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Medical Disclaimer
More about Dexclorfeniramina
- Dexclorfeniramina Side Effects
- During Pregnancy or Breastfeeding
- Drug Images
- Drug Interactions
- 4 Reviews
- Drug class: antihistamines
Consumer resources
- Dexclorfeniramina
Other brands: Polaramine
Professional resources
- Dexclorfeniramina (FDA)
- Dexclorfeniramina (Wolters Kluwer)
Related treatment guides
- Allergic Reactions
- Allergic Rhinitis
What other drugs will affect Dexclorfeniramina?
Do not take Dexclorfeniramina if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A very dangerous drug interaction could occur, leading to serious side effects.
Talk to your pharmacist before taking other over-the-counter cough, cold, allergy, or insomnia medications. These products may contain medicines similar to Dexclorfeniramina, which could lead to an antihistamine overdose.
Before taking this medication, tell your doctor if you are taking any of the following medicines:
-
anxiety or sleep medicines such as alprazolam (Xanax), diazepam (Valium), chlordiazepoxide (Librium), temazepam (Restoril), or triazolam (Halcion);
-
medications for depression such as amitriptyline (Elavil), doxepin (Sinequan), nortriptyline (Pamelor), fluoxetine (Prozac), sertraline (Zoloft), or paroxetine (Paxil); or
-
any other medications that make you feel drowsy, sleepy, or relaxed.
Drugs other than those listed here may also interact with Dexclorfeniramina. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.
Dexclorfeniramina interactions
MAOI may prolong & enhance antihistamine effects which can lead to severe hypotension. W/ alcohol, TCAs, barbiturate or other antidepressants may enhance sedative effect of Dexclorfeniramina maleate.
References
- FDA/SPL Indexing Data. "3Q9Q0B929N: The UNique Ingredient Identifier (UNII) is an alphanumeric substance identifier from the joint FDA/USP Substance Registration System (SRS).". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
- MeSH. "Histamine H1 Antagonists". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
- European Chemicals Agency - ECHA. "dexchlorpheniramine: The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness.". https://echa.europa.eu/ (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Dexclorfeniramina are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Dexclorfeniramina. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported frequency of use
No survey data has been collected yet2 consumers reported doses
What doses of Dexclorfeniramina drug you have used?The drug can be in various doses. Most anti-diabetic, anti-hypertensive drugs, pain killers, or antibiotics are in different low and high doses and prescribed by the doctors depending on the severity and demand of the condition suffered by the patient. In our reports, ndrugs.com website users used these doses of Dexclorfeniramina drug in following percentages. Very few drugs come in a fixed dose or a single dose. Common conditions, like fever, have almost the same doses, e.g., [acetaminophen, 500mg] of drug used by the patient, even though it is available in various doses.
| Users | % | ||
|---|---|---|---|
| 1-5mg | 2 | 100.0% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
